DHODH-IN-11
DHODH-IN-11 (Compound 14b) is a Leflunomide derivative and a weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03[1].
Product Specifications
CAS Number
[1263303-95-2]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Dihydroorotate Dehydrogenase; DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dhodh-in-11.html
Purity
99.69
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(C2=CC=CC=C2)C=C1)/C(C#N)=N/O
Molecular Formula
C15H11N3O2
Molecular Weight
265.27
Precautions
H302, H315, H319, H335
References & Citations
[1]Giorgis M, et al. 1,2,5-Oxadiazole analogues of leflunomide and related compounds. Eur J Med Chem. 2011 Jan;46 (1) :383-92.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant SPARC Related Modular Calcium Binding Protein 1 (SMOC1)
Recombinant SPARC Related Modular Calcium Binding Protein 1 (SMOC1)
Recombinant SPARC Related Modular Calcium Binding Protein 1 (SMOC1)
Recombinant SPARC Related Modular Calcium Binding Protein 1 (SMOC1)
Recombinant SPARC Related Modular Calcium Binding Protein 1 (SMOC1)